We are pleased to announce that the final Reference Case Guidelines for Benefit-Cost Analysis in Global Health and Development are now available here. These guidelines discuss the theory and practice of benefit-cost analysis, providing detailed information on diverse topics such as structuring the analysis, converting values across countries and over time, valuing changes in the risk of illness and death, addressing uncertainty, and reporting the results.
Development of these guidelines was funded by the Bill & Melinda Gates Foundation. The authors include Lisa A. Robinson, James K. Hammitt, Michele Cecchini, Kalipso Chalkidou, Karl Claxton, Maureen Cropper, Patrick Hoang-Vu Eozenou, David de Ferranti, Anil B. Deolalikar, Frederico Guanais, Dean T. Jamison, Soonman Kwon, Jeremy A. Lauer, Lucy O’Keeffe, Damian Walker, Dale Whittington, Thomas Wilkinson, David Wilson, and Brad Wong. The guidelines are supported by a series of methods papers and case studies, many of which are included in a special open-access issue of the Journal of Benefit-Cost Analysis.
The project team will be hosting a workshop, The Benefit-Cost Analysis Reference Case: What It Is and How to Use It, at the International Health Economics Association meeting in Basel, Switzerland on Sunday, July 14, 2019. The benefit-cost analysis workshop will be held from 1:00 pm – 4:30 pm on Sunday, in the same building as the two-day Immunization Economics pre-Congress session. If you are interested in attending both, you may participate in the Immunization Economics pre-congress session for 1.5 days (all day Saturday and Sunday morning - sign up here), then participate in the benefit-cost analysis workshop Sunday afternoon. We hope to see you there!
Learn more about this project here: https://sites.sph.harvard.edu/bcaguidelines/